Live birth after fresh embryo transfer vs elective embryo cryopreservation/frozen embryo transfer in women with polycystic ovary syndrome undergoing IVF (FreFro-PCOS): study protocol for a multicenter, prospective, randomized controlled clinical trial

Trials

Zi-Jiang Chen⁸  Heping Zhang⁵  Richard S Legro³  Bo Zhang⁴  Yunxia Cao⁶  Jiayin Liu⁷  Yun Sun¹  Xiaoyan Liang²  Daimin Wei⁸  Yuhua Shi⁸ 

[1] Reproductive Medical Center of RenJi Hospital, Shanghai Jiaotong University School of Medicine, No. 1630 Dong Fang Road, Shanghai 200127, China;Reproductive Medical Center of the Sixth Affiliated Hospital, Sun Yat-Sen University, No. 17 Sogoulin Road, Tianhe district, Guangzhou 510655, China;Department of Obstetrics and Gynecology, Penn State University College of Medicine, 500 University Drive, Hershey, PA 17033, USA;Reproductive Medical Center, Guangxi Maternal and Child Health Hospital, No. 225 Xin Yang Road, Nanning 530003, China;Department of Biostatistics, Yale University School of Public Health, 60 College Street, New Haven, CT 06510, USA;Reproductive Medical Center of the first Affiliated Hospital, Anhui Medical University, No. 218 Ji Xi Road, Hefei 230022, China;Reproductive Medical Center of Jiangsu Province Hospital, No.300 Guangzhou Road, Nanjing 210029, China;Center for Reproductive Medicine, Shandong Provincial Hospital Affiliated to Shandong University, Reproductive Medical Hospital affiliated to Shandong University, No. 157 Jing Liu Street, Shizhong district, Jinan 250001, China

关键词: Polycystic ovarian syndrome;    Live birth;    In vitro fertilization;    Frozen–thawed embryo transfer;   

Others  :  806560
DOI  :  10.1186/1745-6215-15-154

 received in 2013-12-06, accepted in 2014-04-17,  发布年份 2014

【 摘 要 】

Background

Polycystic ovary syndrome (PCOS) patients are at increased risk of pregnancy complications, which may impair pregnancy outcome. Transfer of fresh embryos after superovulation may lead to abnormal implantation and placentation and further increase risk for pregnancy loss and complications. Some preliminary data suggest that elective embryo cryopreservation followed by frozen–thawed embryo transfer into a hormonally primed endometrium could result in a higher clinical pregnancy rate than that achieved by fresh embryo transfer.

Methods/Design

This study is a multicenter, prospective, randomized controlled clinical trial (1:1 treatment ratio of fresh vs. elective frozen embryo transfers).. A total of 1,180 infertile PCOS patients undergoing the first cycle of in vitro fertilization (IVF) or intracytoplasmic sperm injection will be enrolled and randomized into two parallel groups. Participants in group A will undergo fresh embryo transfer on day 3 after oocyte retrieval, and participants in group B will undergo elective embryo cryopreservation after oocyte retrieval and frozen–thawed embryo transfer in programmed cycles. The primary outcome is the live birth rate. Our study is powered at 80 to detect an absolute difference of 10 at the significance level of 0.01 based on a two-sided test.

Discussion

We hypothesize that elective embryo cryopreservation and frozen–thawed embryo transfer will reduce the incidence of pregnancy complications and increase the live birth rate in PCOS patients who need IVF to achieve pregnancy.

Trial registration

ClinicalTrials.gov Identifier: NCT01841528

【 授权许可】

   
2014 Shi et al.; licensee BioMed Central Ltd.

【 参考文献 】

• [1]Balen AH, Tan SL, MacDougall J, Jacobs HS: Miscarriage rates following in-vitro fertilization are increased in women with polycystic ovaries and reduced by pituitary desensitization with buserelin. Hum Reprod 1993, 8:959-964.
• [2]Boomsma CM, Eijkemans MJ, Hughes EG, Visser GH, Fauser BC, Macklon NS: A meta-analysis of pregnancy outcomes in women with polycystic ovary syndrome. Hum Reprod Update 2006, 12:673-683.
• [3]Hayashi M, Nakai A, Satoh S, Matsuda Y: Adverse obstetric and perinatal outcomes of singleton pregnancies may be related to maternal factors associated with infertility rather than the type of assisted reproductive technology procedure used. Fertil Steril 2012, 98:922-928.
• [4]Chen XK, Wen SW, Bottomley J, Smith GN, Leader A, Walker MC: In vitro fertilization is associated with an increased risk for preeclampsia. Hypertens Pregnancy 2009, 28:1-12.
• [5]Thomopoulos C, Tsioufis C, Michalopoulou H, Makris T, Papademetriou V, Stefanadis C: Assisted reproductive technology and pregnancy-related hypertensive complications: a systematic review. J Hum Hypertens 2013, 27:148-157.
• [6]Haavaldsen C, Tanbo T, Eskild A: Placental weight in singleton pregnancies with and without assisted reproductive technology: a population study of 536,567 pregnancies. Hum Reprod 2012, 27:576-582.
• [7]Maheshwari A, Pandey S, Shetty A, Hamilton M, Bhattacharya S: Obstetric and perinatal outcomes in singleton pregnancies resulting from the transfer of frozen thawed versus fresh embryos generated through in vitro fertilization treatment: a systematic review and meta-analysis. Fertil Steril 2012, 98:368-377. e1–e9
• [8]Kalra SK, Ratcliffe SJ, Coutifaris C, Molinaro T, Barnhart KT: Ovarian stimulation and low birth weight in newborns conceived through in vitro fertilization. Obstet Gynecol 2011, 118:863-871.
• [9]Sazonova A, Källen K, Thurin-Kjellberg A, Wennerholm UB, Bergh C: Obstetric outcome in singletons after in vitro fertilization with cryopreserved/thawed embryos. Hum Reprod 2012, 27:1343-1350.
• [10]Imudia AN, Awonuga AO, Doyle JO, Kaimal AJ, Wright DL, Toth TL, Styer AK: Peak serum estradiol level during controlled ovarian hyperstimulation is associated with increased risk of small for gestational age and preeclampsia in singleton pregnancies after in vitro fertilization. Fertil Steril 2012, 97:1374-1379.
• [11]Farhi J, Ben-Haroush A, Andrawus N, Pinkas H, Sapir O, Fisch B, Ashkenazi J: High serum oestradiol concentrations in IVF cycles increase the risk of pregnancy complications related to abnormal placentation. Reprod Biomed Online 2010, 21:331-337.
• [12]Imudia AN, Awonuga AO, Kaimal AJ, Wright DL, Styer AK, Toth TL: Elective cryopreservation of all embryos with subsequent cryothaw embryo transfer in patients at risk for ovarian hyperstimulation syndrome reduces the risk of adverse obstetric outcomes: a preliminary study. Fertil Steril 2013, 99:168-173.
• [13]Moher D, Hopewell S, Schulz KF, Montori V, Gøtzsche PC, Devereaux PJ, Elbourne D, Egger M, Altman DG, Consolidated Standards of Reporting Trials Group: CONSORT 2010 Explanation and Elaboration: updated guidelines for reporting parallel group randomized trials. J Clin Epidemiol 2010, 63:e1-e37. A published erratum appears in J Clin Epidemiol 2012, 65:351
• [14]Chen ZJ, Zhang YW, Liu JY, Liang XY, Yu Q, Qiao J, Lin JF, Yang DZ, Cao YX, Shi YH, Wu XK, Tian QJ: China diagnosis criteria of polycystic ovarian syndrome diagnosis [in Chinese]. Zhonghua Fu Chan Ke Za Zhi 2012, 47:74-75.
• [15]Hatch R, Rosenfield RL, Kim MH, Tredway D: Hirsutism: implications, etiology, and management. Am J Obstet Gynecol 1981, 140:815-830.
• [16]Balen AH, Laven JS, Tan SL, Dewailly D: Ultrasound assessment of the polycystic ovary: international consensus definitions. Hum Reprod Update 2003, 9:505-514.
• [17]Hong Y, Zhou YW, Tao J, Wang SX, Zhao XM: Do polymorphic variants of chromosomes affect the outcome of in vitro fertilization and embryo transfer treatment? Hum Reprod 2011, 26:933-940.
• [18]De Placido G, Mollo A, Alviggi C, Strina I, Varricchio MT, Ranieri A, Colacurci N, Tolino A, Wilding M: Rescue of IVF cycles by HMG in pituitary down-regulated normogonadotrophic young women characterized by a poor initial response to recombinant FSH. Hum Reprod 2001, 16:1875-1879.
• [19]Commenges-Ducos M, Piault S, Papaxanthos A, Ribes C, Dallay D, Commenges D: Recombinant follicle-stimulating hormone versus human menopausal gonadotropin in the late follicular phase during ovarian hyperstimulation for in vitro fertilization. Fertil Steril 2002, 78:1049-1054.
• [20]Puissant F, Van Rysselberge M, Barlow P, Deweze J, Leroy F: Embryo scoring as a prognostic tool in IVF treatment. Hum Reprod 1987, 2:705-708.
• [21]Xu YP, Xiang HF, Zou WW, Li ZL, Zhang ZG, Zhou P, Cao YX: Clinical application of in vitro maturation of human immature oocytes for infertile women with polycystic ovary syndrome [in Chinese]. Zhonghua Fu Chan Ke Za Zhi 2012, 47:14-18.
• [22]Shapiro BS, Daneshmand ST, Garner FC, Aguirre M, Hudson C, Thomas S: Evidence of impaired endometrial receptivity after ovarian stimulation for in vitro fertilization: a prospective randomized trial comparing fresh and frozen-thawed embryo transfer in normal responders. Fertil Steril 2011, 96:344-348.
• [23]Shapiro BS, Daneshmand ST, Garner FC, Aguirre M, Hudson C, Thomas S: Evidence of impaired endometrial receptivity after ovarian stimulation for in vitro fertilization: a prospective randomized trial comparing fresh and frozen-thawed embryo transfers in high responders. Fertil Steril 2011, 96:516-518.